{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:29:17Z","timestamp":1793284157094,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370348"],"award-info":[{"award-number":["82370348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070376"],"award-info":[{"award-number":["82070376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873491"],"award-info":[{"award-number":["81873491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113825","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:39:18Z","timestamp":1733953158000},"page":"113825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Atractylenolide-III restrains cardiac fibrosis after myocardial infarction via suppression of the RhoA\/ROCK1 and ERK1\/2 pathway"],"prefix":"10.1016","volume":"145","author":[{"given":"Xuelian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113825_b0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.113825_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104744","article-title":"Interleukin-34-NF-\u03baB signaling aggravates myocardial ischemic\/reperfusion injury by facilitating macrophage recruitment and polarization","volume":"95","author":"Zhuang","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104792","article-title":"Disease trajectories following myocardial infarction: insights from process mining of 145 million hospitalisation episodes","volume":"96","author":"Hayward","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104765","article-title":"Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular events","volume":"95","author":"Lidgard","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.792885","article-title":"Therapeutic peptides to treat myocardial ischemia-reperfusion injury","volume":"9","author":"Fernandez Rico","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2024.113825_b0030","doi-asserted-by":"crossref","first-page":"1237210","DOI":"10.3389\/fphar.2023.1237210","article-title":"The efficacy and safety of sacubitril\/valsartan compared with ACEI\/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Gao","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.intimp.2024.113825_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104274","article-title":"Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling","volume":"85","author":"Zhou","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104164","article-title":"Exercise-derived peptide protects against pathological cardiac remodeling","volume":"82","author":"Yin","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104359","article-title":"Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling","volume":"86","author":"Xie","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113825_b0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131545","article-title":"Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction","volume":"4","author":"Schroer","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2024.113825_b0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.121.319482","article-title":"Matricellular protein cilp1 promotes myocardial fibrosis in response to myocardial infarction","volume":"129","author":"Zhang","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2024.113825_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2018.08.022","article-title":"TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice","volume":"36","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.intimp.2024.113825_b0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2024.113825_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104863","article-title":"Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure","volume":"98","author":"Qian","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104108","article-title":"Targeting miR-30d reverses pathological cardiac hypertrophy","volume":"81","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2024.113825_b0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","article-title":"Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction","volume":"142","author":"Ruiz-Villalba","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2024.113825_b0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2024.113825_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2024.113825_b0105","doi-asserted-by":"crossref","first-page":"14287","DOI":"10.1038\/ncomms14287","article-title":"Cellular mechano-environment regulates the mammary circadian clock","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.113825_b0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3892\/etm.2013.935","article-title":"The role of the Rho\/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models","volume":"5","author":"Gao","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.113825_b0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/np100686a","article-title":"Blockade of IL-6 secretion pathway by the sesquiterpenoid atractylenolide III","volume":"74","author":"Kang","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2024.113825_b0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuroscience.2015.01.060","article-title":"Neuroprotection and mechanisms of atractylenolide III in preventing learning and memory impairment induced by chronic high-dose homocysteine administration in rats","volume":"290","author":"Zhao","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2024.113825_b0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/08923973.2020.1806871","article-title":"Atractylenolide III attenuates bleomycin-induced experimental pulmonary fibrosis and oxidative stress in rat model via Nrf2\/NQO1\/HO-1 pathway activation","volume":"42","author":"Huai","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2024.113825_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13892","article-title":"Atractylenolide III alleviates isoflurane-induced injury in rat hippocampal neurons by activating the PI3K\/Akt\/mTOR pathway","volume":"45","author":"Zhu","year":"2021","journal-title":"J. Food Biochem."},{"issue":"12","key":"10.1016\/j.intimp.2024.113825_b0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circulation research"},{"key":"10.1016\/j.intimp.2024.113825_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117323","article-title":"A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK\/p38 MAPK signaling pathway","volume":"319","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.113825_b0145","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1002\/ptr.7929","article-title":"Atractylenolide-III alleviates osteoarthritis and chondrocyte senescence by targeting NF-\u03baB signaling","volume":"37","author":"Xu","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.113825_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117240","article-title":"Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3\/ASC\/Caspase-1 signaling pathway","volume":"319","author":"Hou","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.113825_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101151","article-title":"Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction","volume":"22","author":"Liu","year":"2019","journal-title":"Redox biology"},{"key":"10.1016\/j.intimp.2024.113825_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103370","article-title":"TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-\u03b2\/Smads and ERK1\/2 signaling pathways","volume":"67","author":"Cheng","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2024.113825_b0165","article-title":"Atractylenolide III attenuates muscle wasting in chronic kidney disease via the oxidative stress-mediated PI3K\/AKT\/mTOR pathway","volume":"2019","author":"Wang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.113825_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1149231","article-title":"Atractylenolide III attenuates apoptosis in H9c2 cells by inhibiting endoplasmic reticulum stress through the GRP78\/PERK\/CHOP signaling pathway","volume":"2022","author":"Zuo","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113825_b0175","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.intimp.2024.113825_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.129177","article-title":"microRNA-21, via the HIF-1\u03b1\/VEGF signaling pathway, is involved in arsenite-induced hepatic fibrosis through aberrant cross-talk of hepatocytes and hepatic stellate cells","volume":"266","author":"Sun","year":"2021","journal-title":"Chemosphere"},{"issue":"18","key":"10.1016\/j.intimp.2024.113825_b0185","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.7150\/thno.48561","article-title":"Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2024.113825_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2022.100024","article-title":"Atractylenolide III ameliorated autophagy dysfunction via epidermal growth factor receptor-mammalian target of rapamycin signals and alleviated silicosis fibrosis in mice","volume":"103","author":"Tan","year":"2023","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2024.113825_b0195","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","article-title":"Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u03b1\/NF-\u03baB feedback pathway to inhibit liver fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2024.113825_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113699","article-title":"The antitumor properties of atractylenolides: Molecular mechanisms and signaling pathways","volume":"155","author":"Jiang","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.intimp.2024.113825_b0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3892\/or.2015.4394","article-title":"The natural compound codonolactone attenuates TGF-\u03b21-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells","volume":"35","author":"Fu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2024.113825_b0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpba.2011.09.023","article-title":"Quantitative analysis of atractylenolide I in rat plasma by LC-MS\/MS method and its application to pharmacokinetic study","volume":"58","author":"Li","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.intimp.2024.113825_b0215","doi-asserted-by":"crossref","first-page":"C1732","DOI":"10.1152\/ajpcell.00552.2006","article-title":"Actin-dependent regulation of connective tissue growth factor","volume":"292","author":"Muehlich","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"35","key":"10.1016\/j.intimp.2024.113825_b0220","doi-asserted-by":"crossref","first-page":"2308395","DOI":"10.1002\/advs.202308395","article-title":"DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF-1\u03b1 Ubiquitination and Degradation","volume":"11","author":"Wei","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.intimp.2024.113825_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-170","article-title":"Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA\/ROCK-2\/moesin cascade","volume":"10","author":"He","year":"2010","journal-title":"BMC cancer"},{"key":"10.1016\/j.intimp.2024.113825_b0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-10-79","article-title":"Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells","volume":"10","author":"Nakashima","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2024.113825_b0235","article-title":"Atractylenolide III attenuates angiogenesis in gastric precancerous lesions through the downregulation of delta-like ligand 4","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113825_b0240","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","article-title":"Novel insights into the roles of Rho kinase in cancer","volume":"64","author":"Wei","year":"2016","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"issue":"5","key":"10.1016\/j.intimp.2024.113825_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13582","article-title":"Atractylenolide III predisposes miR-195-5p\/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer","volume":"45","author":"Sheng","year":"2021","journal-title":"Journal of Food Biochemistry"},{"key":"10.1016\/j.intimp.2024.113825_b0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/08923973.2015.1122617","article-title":"Anti-inflammatory activity of atractylenolide III through inhibition of nuclear factor-\u03baB and mitogen-activated protein kinase pathways in mouse macrophages","volume":"38","author":"Ji","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2024.113825_b0255","article-title":"Therapeutic effects and mechanism of Atractylodis rhizoma in acute lung injury: Investigation based on an Integrated approach","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:43:12Z","timestamp":1734637392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S1567576924023476"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113825","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atractylenolide-III restrains cardiac fibrosis after myocardial infarction via suppression of the RhoA\/ROCK1 and ERK1\/2 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113825"}}